ALZpath and Siemens Healthineers Sign Licensing Agreement to Advance Global Access to Blood-Based Alzheimer's Disease Diagnostic Testing [Yahoo! Finance]
SIEMENS AG SPONS ADR (SIEGY)
NASDAQ:AMEX Investor Relations:
siemens.com/investor
Company Research
Source: Yahoo! Finance
CARLSBAD, Calif. Dec. 15, 2025 /PRNewswire/ -- ALZpath, Inc. , a leading developer of innovative diagnostic tools for Alzheimer's disease and related dementias, today announced a licensing agreement with Siemens Healthineers for use of its proprietary pTau217 antibody in the development of a pTau217 assay in the expanding menu of Siemens Healthineers in vitro diagnostic (IVD) tests for Alzheimer's disease. The test is being designed for use on Siemens Healthineers' Atellica immunoassay systems. Blood-based neurodegenerative disease diagnostics, including those for Alzheimer's, are a transformative advancement. The ALZpath pTau217 antibody has shown exceptional performance across a range of platforms to help identify patients with Alzheimer's disease through a simple blood draw. It enables sensitive, accurate detection of Alzheimer's disease pathology with performance comparable to PET imaging and cerebrospinal fluid (CSF) testing —and, via in vitro diagnostic tests, it may be deplo
Show less
Read more
Impact Snapshot
Event Time:
SIEGY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SIEGY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SIEGY alerts
High impacting SIEMENS AG SPONS ADR news events
Weekly update
A roundup of the hottest topics
SIEGY
News
- Siemens (OTCMKTS:SIEGY) is now covered by analysts at Evercore ISI. They set an "outperform" rating on the stock.MarketBeat
- Siemens Mobility and Railpool plan locomotive service hub in Verona [Yahoo! Finance]Yahoo! Finance
- Siemens Healthineers (XTRA:SHL): Assessing Valuation After a Year of Share Price Weakness [Yahoo! Finance]Yahoo! Finance
- Telix and Varian Announce Strategic Theranostics-EBRT Clinical Collaboration [Yahoo! Finance]Yahoo! Finance
- Sainte Catherine, Institut du Cancer Avignon-Provence (ICAP), Becomes the First Center in Europe to Implement the Varian Latest Halcyon Advancements with Identify integration, PerfectKinetix Dynamic Couch and HyperSight for Personalized Radiotherapy [YahoYaho